Fig. 3: The BH4 domain of Bcl-2 inhibits IP3R-mediated Ca2+ release in Bcl-2 KO PACs.
From: BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis

aāc Typical traces of the Fluo-4AM single-cell Ca2+ measurements performed in Bcl-2 KO mouse PACs. At the start of each experiment cells were perfused with NaHEPES containing DMSO (vehicle, Fig.Ā 3a). After establishing the baseline (200ās), ACh (200ānM) was added and IP3R-mediated Ca2+ oscillations were measured for 5āmin. Then, 50āµM of either the control peptide (a), the BH4 domain of Bcl-2 (b) or the BH4 domain of Bcl-XL (c) were added for 10āmin, in the continuous presence of 200ānM ACh. d Quantification of the experiments: The area under the curve per second (AUC/sec) of the ACh-induced Ca2+ release after peptide addition (10āmin recording) was compared to the AUC/sec before peptide addition (5āmin recording). Each data point represents the measurement of an individual cell. The average valuesā±āSEM are shown (P-value <0.0001). At least three independent experiments were performed per condition (Nāā„ā3). For each conditionĀ at least 35 cells were recorded